SA4Ag vaccine
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Staphylococcal Infections
Conditions
Staphylococcal Infections
Trial Timeline
Jan 1, 2015 → Feb 1, 2015
NCT ID
NCT02364596About SA4Ag vaccine
SA4Ag vaccine is a phase 1 stage product being developed by Pfizer for Staphylococcal Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT02364596. Target conditions include Staphylococcal Infections.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02364596 | Phase 1 | Completed |
Competing Products
20 competing products in Staphylococcal Infections